title: [Copper deficiency with SMON-like neurological symptoms and macrocytic anemia].
authors.affiliation: Department of Neurology, Tokushima University Hospital, Tokushima.
authors.forename: Youhei
authors.initials: Y
authors.lastname: Mukai
authors.forename: Koutarou
authors.initials: K
authors.lastname: Asanuma
authors.forename: Atsuko
authors.initials: A
authors.lastname: Mori
authors.forename: Masaki
authors.initials: M
authors.lastname: Kamada
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Kawabata
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nodera
authors.forename: Syunya
authors.initials: S
authors.lastname: Nakane
authors.forename: Takao
authors.initials: T
authors.lastname: Mitsui
authors.forename: Yuishin
authors.initials: Y
authors.lastname: Izumi
authors.forename: Ryuuji
authors.initials: R
authors.lastname: Kaji
mesh_terms: D000748:Anemia, Macrocytic / Q000188:drug therapy / Q000209:etiology*; D001259:Ataxia / Q000188:drug therapy / Q000209:etiology; D003300:Copper / Q000172:deficiency*; D019327:Copper Sulfate / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D009187:Myelitis / Q000188:drug therapy / Q000209:etiology; D009902:Optic Neuritis / Q000188:drug therapy / Q000209:etiology; D010554:Personality Disorders / Q000188:drug therapy / Q000209:etiology; D011115:Polyneuropathies / Q000188:drug therapy / Q000209:etiology; D016896:Treatment Outcome
chemical_list: D003300:Copper; D019327:Copper Sulfate